175 related articles for article (PubMed ID: 34728470)
1. Postdiagnosis BMI Change Is Associated with Non-Small Cell Lung Cancer Survival.
Yuan Q; Du M; Loehrer E; Johnson BE; Gainor JF; Lanuti M; Li Y; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):262-268. PubMed ID: 34728470
[TBL] [Abstract][Full Text] [Related]
2. Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.
Shepshelovich D; Xu W; Lu L; Fares A; Yang P; Christiani D; Zhang J; Shiraishi K; Ryan BM; Chen C; Schwartz AG; Tardon A; Wu X; Schabath MB; Teare MD; Le Marchand L; Zhang ZF; Field JK; Brenner H; Diao N; Xie J; Kohno T; Harris CC; Wenzlaff AS; Fernandez-Tardon G; Ye Y; Taylor F; Wilkens LR; Davies M; Liu Y; Barnett MJ; Goodman GE; Morgenstern H; Holleczek B; Brown MC; Liu G; Hung RJ
J Thorac Oncol; 2019 Sep; 14(9):1594-1607. PubMed ID: 31163278
[TBL] [Abstract][Full Text] [Related]
3. Postdiagnosis Body Mass Index, Weight Change, and Mortality From Prostate Cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic Prostate Cancer.
Troeschel AN; Hartman TJ; Jacobs EJ; Stevens VL; Gansler T; Flanders WD; McCullough LE; Wang Y
J Clin Oncol; 2020 Jun; 38(18):2018-2027. PubMed ID: 32250715
[TBL] [Abstract][Full Text] [Related]
4. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams.
Kroenke CH; Neugebauer R; Meyerhardt J; Prado CM; Weltzien E; Kwan ML; Xiao J; Caan BJ
JAMA Oncol; 2016 Sep; 2(9):1137-45. PubMed ID: 27196302
[TBL] [Abstract][Full Text] [Related]
6. Exploring the optimal indicator of short-term peridiagnosis weight dynamics to predict cancer survival: A multicentre cohort study.
Yin L; Zhang L; Li L; Liu M; Zheng J; Xu A; Lyu Q; Feng Y; Guo Z; Ma H; Li J; Chen Z; Wang H; Li Z; Zhou C; Gao X; Weng M; Yao Q; Li W; Li T; Shi H; Xu H
J Cachexia Sarcopenia Muscle; 2024 Apr; ():. PubMed ID: 38644549
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery.
Nakagawa T; Toyazaki T; Chiba N; Ueda Y; Gotoh M
Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):560-6. PubMed ID: 27252238
[TBL] [Abstract][Full Text] [Related]
8. Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation.
Chen YM; Lai CH; Lin CY; Tsai YH; Chang YC; Chen HC; Tseng CC; Chang HC; Huang KT; Chen YC; Fang WF; Wang CC; Chao TY; Lin MC
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836017
[TBL] [Abstract][Full Text] [Related]
9. Predictors of survival in patients with non-small cell lung cancer.
Luo J; Chen YJ; Narsavage GL; Ducatman A
Oncol Nurs Forum; 2012 Nov; 39(6):609-16. PubMed ID: 23107855
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.
Imai H; Kishikawa T; Minemura H; Yamada Y; Ibe T; Yamaguchi O; Mouri A; Hamamoto Y; Kanazawa K; Kasai T; Kaira K; Kaburagi T; Minato K; Kobayashi K; Kagamu H
Cancer Med; 2021 Oct; 10(20):6971-6984. PubMed ID: 34414673
[TBL] [Abstract][Full Text] [Related]
11. Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis.
Schlesinger S; Siegert S; Koch M; Walter J; Heits N; Hinz S; Jacobs G; Hampe J; Schafmayer C; Nöthlings U
Cancer Causes Control; 2014 Oct; 25(10):1407-18. PubMed ID: 25037235
[TBL] [Abstract][Full Text] [Related]
12. The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer.
Sepesi B; Gold KA; Correa AM; Heymach JV; Vaporciyan AA; Roszik J; Dmitrovsky E; Liu X
J Thorac Oncol; 2017 Aug; 12(8):1280-1287. PubMed ID: 28552766
[TBL] [Abstract][Full Text] [Related]
13. Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer.
Derman BA; Macklis JN; Azeem MS; Sayidine S; Basu S; Batus M; Esmail F; Borgia JA; Bonomi P; Fidler MJ
BMC Cancer; 2017 Feb; 17(1):141. PubMed ID: 28209123
[TBL] [Abstract][Full Text] [Related]
14. Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer.
Ran H; Ma J; Cai L; Zhou H; Yuan Z; Chen Y; Chang W; Huang Y; Xiao Y
BMC Cancer; 2022 Jan; 22(1):93. PubMed ID: 35062903
[TBL] [Abstract][Full Text] [Related]
15. Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC).
Lam VK; Bentzen SM; Mohindra P; Nichols EM; Bhooshan N; Vyfhuis M; Scilla KA; Feigenberg SJ; Edelman MJ; Feliciano JL
Lung Cancer; 2017 Feb; 104():52-57. PubMed ID: 28213000
[TBL] [Abstract][Full Text] [Related]
16. Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients.
Masel EK; Berghoff AS; Füreder LM; Heicappell P; Schlieter F; Widhalm G; Gatterbauer B; Dieckmann U; Birner P; Bartsch R; Schur S; Watzke HH; Zielinski CC; Preusser M
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28488812
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.
Heiden BT; Eaton DB; Engelhardt KE; Chang SH; Yan Y; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
JAMA Netw Open; 2021 May; 4(5):e2111613. PubMed ID: 34042991
[TBL] [Abstract][Full Text] [Related]
18. Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials.
Dahlberg SE; Schiller JH; Bonomi PB; Sandler AB; Brahmer JR; Ramalingam SS; Johnson DH
J Thorac Oncol; 2013 Sep; 8(9):1121-7. PubMed ID: 23887169
[TBL] [Abstract][Full Text] [Related]
19. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
Cadranel J; Mauguen A; Faller M; Zalcman G; Buisine MP; Westeel V; Longchampt E; Wislez M; Coudert B; Daniel C; Chetaille B; Michiels S; Blons H; Solassol J; De Fraipont F; Foucher P; Urban T; Lacroix L; Poulot V; Quoix E; Antoine M; Danton G; Morin F; Chouaid C; Pignon JP
J Thorac Oncol; 2012 Oct; 7(10):1490-502. PubMed ID: 22982650
[TBL] [Abstract][Full Text] [Related]
20. Lower Pectoralis Muscle Area Is Associated with a Worse Overall Survival in Non-Small Cell Lung Cancer.
Kinsey CM; San José Estépar R; van der Velden J; Cole BF; Christiani DC; Washko GR
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):38-43. PubMed ID: 27197281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
